UCSF digital therapy spinout Akili Interactive Labs previously disclosed $97.4m in funding from investors including Amgen and Merck Group.
Akili Interactive Labs, a US-based digital therapy spinout from University of California San Francisco (UCSF), has secured an additional licence agreement with the Regents of the University of California.
The licence covers clinical-stage digital technology powered by neural systems targeting both cognitive function and physical activity to improve outcomes for patients with a wide range of medical conditions.
The therapy is delivered through a motion-capture video game interface to provide the patient with an immersive and personalised experience.…
